Moroni, Gabriella

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

Fanouriakis, A., Kostopoulou, M., Alunno, A., Aringer, M., Bajema, I., Boletis, J. N., Cervera, R., Doria, A., Gordon, C., Govoni, M., et al. (2019) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 2,011

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

Heerspink, H. J. L., Greene, T., Tighiouart, H., Gansevoort, R. T., Coresh, J., Simon, A. L., Chan, T. M., Hou, F. F., Lewis, J. B., Locatelli, F., et al. (2019) · The Lancet Diabetes & Endocrinology

Chronic Kidney Disease and DiabetesStatistical Methods in Clinical Trials

Cited by 397

IL-10–producing forkhead box protein 3–negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus

Facciotti, F., Gagliani, N., Häringer, B., Alfen, J. S., Penatti, A., Maglie, S., Paroni, M., Iseppon, A., Moro, M., Crosti, M. C., et al. (2016) · Journal of Allergy and Clinical Immunology

T-cell and B-cell ImmunologySystemic Lupus Erythematosus Research

Cited by 43

Remission and withdrawal of therapy in lupus nephritis

Moroni, G., Raffiotta, F., & Ponticelli, C. (2016) · Journal of Nephrology

Systemic Lupus Erythematosus ResearchRenal Diseases and Glomerulopathies

Cited by 31